Company / Total Debt
BioLife Solutions, Inc. Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$5.0M
FY2025
5-year range
$5.0M / $25.6M
FY2021-FY2025
Trend
-68.7%
vs FY2024
Sector context
#100 of 102
Health Care
What the data says
Among 102 Health Care companies, BioLife Solutions, Inc. is in the top 2% for total debt. Total Debt has declined for 3 consecutive years, from $26M in FY2022 to $5M in FY2025.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of +31.5%.
Improved from $24M to $5M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -42.0%
- 5-Year CAGR
- +31.5%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 102This company $5.0M Sector average $4.5B
▼
-99.9% below sector average
Key checks
Key Insights
- BioLife Solutions, Inc.'s total debt has declined for 3 consecutive years.
- 5-year CAGR of +31.5%, indicating consistent growth.
- In FY2025, total debt decreased 68.7% year-over-year.
- Ranks #100 out of 102 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0M | -68.7% |
| FY2024 | $15.9M | -33.2% |
| FY2023 | $23.8M | -6.9% |
| FY2022 | $25.6M | +254.9% |
| FY2021 | $7.2M | +468.6% |
| FY2020 | $1.3M | +9661.5% |
| FY2019 | $13.0K | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $4.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026